Immutep (IMMP) Liabilities and Shareholders Equity (2011 - 2025)

Immutep (IMMP) posted Liabilities and Shareholders Equity of $96.6 million for Q4 2025, down 3.87% on a QoQ basis from $100.5 million in Q2 2025, and down 18.94% year-over-year from $119.2 million in Q4 2024.

Immutep (IMMP) Liabilities and Shareholders Equity (2011 - 2025) Analysis & Trends

Immutep's Liabilities and Shareholders Equity history runs 15 years deep, the most recent figure standing at $96.6 million for Q4 2025.

  • Quarterly Liabilities and Shareholders Equity fell 18.94% year-over-year to $96.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $449.3 million (up 4.19% YoY) and the FY2025 annual result came in at $100.5 million, down 24.32% from the prior year.
  • Liabilities and Shareholders Equity was $96.6 million for Q4 2025 at Immutep, down from $100.5 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $132.8 million in Q2 2024 and bottomed at $56.5 million in Q4 2022.
  • A 5-year average of $90.9 million and a median of $92.1 million in 2021 frame the typical range for Liabilities and Shareholders Equity.
  • Annual changes were most pronounced in 2021 — Liabilities and Shareholders Equity jumped 106.83% — and 2022, when it slumped 35.47%.
  • Immutep's Liabilities and Shareholders Equity stood at $87.6 million in 2021, then tumbled by 35.47% to $56.5 million in 2022, then surged by 42.6% to $80.6 million in 2023, then surged by 47.96% to $119.2 million in 2024, then dropped by 18.94% to $96.6 million in 2025.
  • Business Quant data shows IMMP's Liabilities and Shareholders Equity at $96.6 million in Q4 2025, $100.5 million in Q2 2025, and $119.2 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 311.58 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 78.88 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 8.55 Bn
4 NuCana 279.75 Bn 279.75 Bn - 39.68 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 26.48 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 40.87 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 811.27 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 10.03 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 2.25 Bn
10 Immutep 567.77 Mn 567.77 Mn - 96.65 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 96.65 Mn
Jun 30, 2025 100.54 Mn
Dec 31, 2024 119.23 Mn
Jun 30, 2024 132.85 Mn
Dec 31, 2023 80.59 Mn
Jun 30, 2023 98.55 Mn
Dec 31, 2022 56.51 Mn
Jun 30, 2022 73.18 Mn
Dec 31, 2021 87.57 Mn
Jun 30, 2021 63.17 Mn
Dec 31, 2020 55.90 Mn
Jun 30, 2020 30.54 Mn
Dec 31, 2019 29.35 Mn
Jun 30, 2019 23.92 Mn
Dec 31, 2018 34.61 Mn
Jun 30, 2018 35.58 Mn
Jun 30, 2017 26.27 Mn
Mar 31, 2017 26.78 Mn
Dec 31, 2016 28.63 Mn
Jun 30, 2016 31.78 Mn